Ozone Pharmaceuticals eyes Rs 1,000 crore topline in next 3

According to the statement, Ozone launched its Molecule initiative with a vision to become the world's foremost pain management company.

Related Keywords

India , Saurav Banerjee , Ozone Pharmaceuticals Group , Ozone Group , Ozone Pharmaceuticals On , Ozone Pharmaceuticals , Pharmaceuticals Group Director Saurav Banerjee , Ozone Pharma , Turnover , Pain Management Company , Molecule Initiative , Cmd Sc Sehgal ,